Bezoar: Difference between revisions

No edit summary
Line 9: Line 9:
*Gastric dysmotility
*Gastric dysmotility
*Gastric outlet obstruction
*Gastric outlet obstruction
*Dehydration
*[[Dehydration]]
*Medications
*Medications
**[[Anticholinergic]]
**[[Anticholinergic]]
Line 19: Line 19:
*Pharmacobezoars (medications, especially overdoses of sustained-release medications
*Pharmacobezoars (medications, especially overdoses of sustained-release medications
*Phytobezoars (indigestible plant  material)
*Phytobezoars (indigestible plant  material)
*Trichobezoar (hair)
*[[trichotillomania|Trichobezoar]] (hair)


==Clinical Features==
==Clinical Features==
Line 26: Line 26:
*[[Nausea and vomiting]]
*[[Nausea and vomiting]]
*[[Diarrhea]]
*[[Diarrhea]]
*Gastric ulcers
*[[gastric ulcer disease|Gastric ulcers]]


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 19:35, 29 September 2019

Background

  • Mass within the gastrointestinal system
  • Made up of organic or inorganic material
  • Commonly from eating hair or indigestible materials
  • Risk factors include intellectual disability or emotional disturbance
  • More common females aged 10 to 19 years of age

Risk Factors

Types of Bezoars

  • Food boluses
  • Lactobezoar (seen in premature infants receiving formula)
  • Pharmacobezoars (medications, especially overdoses of sustained-release medications
  • Phytobezoars (indigestible plant material)
  • Trichobezoar (hair)

Clinical Features

Differential Diagnosis

Epigastric Pain

Evaluation

Management

  • Removal either endoscopically if small but may require surgical removal when large

Disposition

See Also

External Links

References